When an SSDI claim gets denied, most people assume the system is simply stacked against them. The reality is more layered — and understanding where denials cluster across the appeals process can help claimants make smarter decisions about how to proceed.
Before looking at denial rates, it helps to understand the structure. After an initial denial, claimants move through up to four stages:
Each stage has its own logic, timeline, and approval pattern.
The Social Security Administration publishes annual workload data, and the patterns are consistent enough to be useful — even if exact percentages shift year to year.
| Stage | Approximate Denial Rate |
|---|---|
| Initial Application | ~60–65% |
| Reconsideration | ~85–90% |
| ALJ Hearing | ~45–55% (meaning roughly half are approved) |
| Appeals Council | ~80–90%+ |
A few things stand out in that table. Reconsideration is the stage with the highest denial rate — the vast majority of claimants who reach that level are denied again, often because the review is based on the same medical record without a live hearing. Many disability advocates treat reconsideration as a formality that must be completed before reaching the ALJ stage, which has historically been the most favorable point in the process for claimants.
The ALJ hearing is where outcomes are most variable and where claimants with stronger medical documentation and legal representation tend to fare better. Approval rates at this stage have ranged from around 45% to over 55% in recent years, depending on the judge, the hearing office, and the nature of the claim.
The Appeals Council grants very few outright reversals. When it does act favorably, it most commonly remands the case back to an ALJ for a new hearing rather than granting benefits directly.
The phrase "denied upon appeal" lumps together experiences that are actually quite different. A denial at reconsideration — where no new hearing takes place and the review is largely administrative — is a very different event than a denial at an ALJ hearing, where the claimant had the opportunity to present testimony and submit updated medical evidence.
This matters because the pathway forward after each denial is different:
Each of those steps has its own deadline. Missing a deadline can mean starting the process over from scratch rather than continuing the existing appeal.
Across every stage, the same core factors drive outcomes. Medical evidence is the foundation — specifically whether the record establishes a severe, documented impairment that prevents the claimant from engaging in substantial gainful activity (SGA). For 2025, the SGA threshold for non-blind individuals is $1,620 per month (this adjusts annually).
Beyond diagnosis, reviewers assess Residual Functional Capacity (RFC) — a structured evaluation of what a claimant can still do despite their limitations. A claimant's RFC is compared against their past work history and, if necessary, against other work in the national economy.
Other variables that shape outcomes include:
One structural reality worth naming directly: two states — Michigan and Louisiana — previously participated in a prototype that skipped the reconsideration stage, routing initial denials straight to ALJ hearings. SSA has studied the tradeoffs. Reconsideration was originally designed as a quality-control step, but its very high denial rate has led many claimants and advocates to view it primarily as a required hurdle before reaching the more meaningful ALJ stage.
If you're at the reconsideration stage and receive a denial, that denial is not a final verdict on your claim. It is a procedural step.
Someone with a condition on SSA's Compassionate Allowances list — certain cancers, ALS, early-onset Alzheimer's — may be approved at the initial stage without ever reaching the appeals process. Someone with a less clearly documented condition, such as a mental health impairment, chronic pain disorder, or a condition that fluctuates over time, is more likely to face multiple denials before approval, if approval comes at all.
A claimant who has had continuous, documented treatment with consistent clinical findings will generally fare better at every stage than one who has self-reported symptoms without corresponding medical records. That isn't a judgment about the legitimacy of the condition — it reflects how the evidence standard actually works within the SSA review system.
Aggregate denial rates describe the landscape. They don't describe any individual's claim. The specific condition in your medical file, the language in your treating physician's notes, the way your RFC was assessed, the ALJ assigned to your case, and the point in the process where your claim currently sits — none of that is captured in a national statistic.
The numbers tell you what the terrain looks like. They don't tell you where you stand on it.
